Skip to main content

A case of mistaken identity: classic Kaposi sarcoma misdiagnosed as a diabetic foot ulcer in an atypical patient



The presentation of Kaposi sarcoma is divided into four known clinical subtypes. In this case report we describe classic Kaposi sarcoma in an African-American heterosexual, diabetic, seronegative human immunodeficiency virus male. Classic Kaposi sarcoma is rare in this patient demographic and can be easily misdiagnosed.

Case presentation

The patient presented with a lesion between the fourth and fifth digits of his right foot which was initially diagnosed as a diabetic foot ulcer. Despite local wound care, the lesion did not resolve. A shave biopsy was performed and histopathology findings were consistent with classic Kaposi sarcoma.


The patient tolerated local radiotherapy well and had complete resolution of his pedal lesion. There have been emerging associations between diabetes and Kaposi sarcoma. As such, clinicians should have a low threshold when considering the biopsy of suspicious pedal lesions in patients with diabetes. The utilization of appropriate biopsy technique may lead to the diagnosis of classic KS tumors in populations outside of the current four widely accepted clinical subtypes.


Kaposi sarcoma (KS) is a vascular tumor caused by the proliferation of spindle cells in the endothelium of blood vessels [1]. In the United States there are four widely accepted distinct KS clinical subtypes. Classic KS, typically benign and mostly limited to the hands and the feet, is seen primarily in elderly men of Eastern European and Mediterranean origin [2]. Endemic or African KS is most commonly seen in indigenous Sub-Saharan Africans and is independent of the human immunodeficiency virus (HIV) [3]. Iatrogenic KS is associated with recipients of organ transplants and patients undergoing immunosuppression therapy [4]. Epidemic or acquired immune deficiency syndrome (AIDS) KS is the most common tumor seen in people infected with HIV. This subtype is most frequently described in HIV seropositive homosexual and bisexual men [2, 5]. Each KS clinical subtype is linked through infection of the Kaposi sarcoma-associated herpes virus (KSHV), also known as human herpesvirus 8 (HHV-8) [6]. We present a case describing the unusual presentation of classic KS in a diabetic African-American heterosexual HIV seronegative male.

Case presentation

An 80-year-old African-American male presented to the University of Michigan Hospital and Health Systems Comprehensive Wound Center for ongoing care of a painful right foot fifth digit wound. He first noticed the lesion after stubbing the digit 2 months prior. He presented to his primary care doctor 1 month after the injury and the lesion was diagnosed as a diabetic foot ulcer (DFU). The lesion improved minimally with local wound care. Due to stagnation of the suspected DFU the patient presented to the wound center for further care. Upon initial wound center presentation, a granulomatous mass was noted to the medial aspect of the right fifth digit (Fig. 1). A biopsy of the lesion was subsequently scheduled. However, upon presenting to the biopsy procedure, the patient stated the granulomatous mass had sloughed off in his sock the week prior leaving only a small partial-thickness ulcer (Fig. 2). The patient elected to defer the biopsy as his symptoms had improved. The patient continued regular monthly follow-up at the wound center with development of his wound into two painful papules.

Fig. 1

Right foot medial fifth digit with granulomatous mass

Fig. 2

Right foot fifth digit partial thickness wound with sloughed granulomatous mass

The patient’s past medical history was significant for type 2 diabetes mellitus T2DM, hypertension, hyperlipidemia, asthma, and dementia. He denied a family history of skin lesions and cancer. He did not take any immunosuppressive medication. The patient was a lifelong non-smoker and denied alcohol and illicit drug use. He was married, heterosexual and monogamous. At the time of presentation his last recorded hemoglobin A1c was 6.1%. Clinical examination revealed palpable pedal pulses with triphasic flow to the bilateral dorsalis pedis artery and posterior tibialis artery. His right hallux toe pressure was 126 mmHg and his left hallux toe pressure was 184 mmHg. He had diminished protective sensation, 2 out of 4 sites bilaterally, as tested with 10-g 5.07 Semmes-Weinstein monofilament as per American Diabetes Association guidelines [7]. To the medial aspect of the patient’s right fifth digit were two firm, cyanotic appearing papules. The distal papule measured 0.5 cm in diameter and the proximal papule measured 0.7 cm in diameter (Fig. 3). There were no clinical signs of infection noted to the right foot. As the lesion caused moderate discomfort and did not improve despite 2 months of local care at the wound center, a biopsy of the lesion was again recommended.

Fig. 3

Right foot fifth digit with two distinct cyanotic papules

After obtaining written informed consent a #15 blade was used to perform a shave biopsy of both the right fifth digit proximal and distal papules. The two specimens were labeled appropriately and sent separately to the University of Michigan Hospital and Health Systems pathology laboratory for assessment. The pathology report identified the specimen obtained from the distal papule as the superficial aspect of a hemorrhagic vascular lesion. The specimen from the proximal papule was identified as Kaposi sarcoma, nodular stage, transected at the deep margin. Hematoxylin and eosin stain demonstrated dermal nodules with haphazard spindle cell proliferation of endothelial cells forming vascular spaces which is diagnostic of classic KS (Fig. 4). The tumor cells showed diagnostic positive staining for HHV-8 (Fig. 5).

Fig. 4

Histopathology hematoxylin and eosin stain with magnification 200X showing spindle cell proliferation and slit-like vascular spaces

Fig. 5

Proliferated spindle cells demonstrate positive staining (brown) of the antibody to HHV-8

After the resulting classic KS diagnosis, the patient was referred to the Surgical Oncology Clinic at the University of Michigan Hospital and Health Systems. He underwent a series of blood tests to assess for underlying immunosuppression including HIV testing and a complete blood count with platelet and differential. He was determined to be HIV seronegative without any other clinical findings of immunosuppression. His case was reviewed by the University of Michigan Sarcoma Medical Oncology Department as well as the Multidisciplinary Sarcoma Tumor Board. The consensus of the combined board was local therapy with radiation without surgical intervention. The patient underwent 30 Gy of radiation in 10 fractions directed to the right foot fifth digit. The patient tolerated radiotherapy well and upon finishing his course of therapy, the KS lesion to the right foot had completely resolved. Upon a 10 month follow-up from initiation of radiation, the patient was disease free.


KS is rare in the general population. The disease represents about 1% of all diagnosed cancers worldwide [8]. The case we present is unusual as the clinical characteristics of the patient discussed do not fit those typical of classic KS or any of the other KS subtypes seen in the current literature. Classic KS is seen most commonly in men (male to female ratio 10–15:1) of Mediterranean or Eastern European origin. It is particularly seen in Ashkenazic Jews in their fifth through eighth decade of life [1, 4]. As classic KS most often affects the feet, it is not uncommon for KS lesions to be initially misdiagnosed as diabetic foot ulcers [9,10,11]. There are notable differences that can aid in distinguishing between DFUs and KS lesions. DFUs are typically divided into either neuropathic ulcers or neuroischemic ulcers [12]. Neuropathic ulcers, associated with diabetic peripheral neuropathy, are typically found on the weightbearing surfaces of a well-perfused foot. Common wound locations include the plantar metatarsal heads or the heel. Diabetic neuropathic ulcers are typically painless with well-defined wound margins. An important feature of neuropathic ulcers is peri-ulcer callus development. Callus formation is the result of repetitive mechanical stress, usually pressure and friction, in an insensate foot. If a callus is left intact for a prolonged period of time, the tissue underlying the callus will ulcerate. Neuroischemic ulcers have the underlying etiology of neuropathy and poor arterial perfusion. The foot type is usually pulseless, cool to touch, with atrophic skin and diminished pedal hair. Neuroischemic wounds commonly appear on the margins of the foot such as the foot edge, distal aspects of toes and back of the heel. The wounds can occur spontaneously or as a result of microtrauma [13]. Because of ischemia, neuroischemic wounds can be quite painful. A significant factor of DFUs is that once the underlying etiology is controlled, i.e. pressure or ischemia, the wound should improve or heal with local wound care.

Though the patient in our case study had peripheral neuropathy, classic KS lesions can occur in diabetic patients independent of neuropathy or ischemia. The lesions are usually on the soles and arches of the foot [14]. Pedal interdigital presentation of KS lesions is possible as well, which differs from the usual presentations of DFUs. Also, in contrast to DFUs, it is unusual for a classic KS lesion to initially present as a ulcer, with calloused tissue, or as a blister. KS lesions generally present as painless, violaceous plaques and nodules [15]. The lesions can appear either isolated or in groups. Enlargement and ulceration of a KS lesion occurs over prolonged periods of time [16]. Unlike DFUs, local wound care and removal of the suspected etiology will not result in resolution of the KS lesion as it is a tumor of viral origin.

The case presented serves as an example of the necessity to biopsy pedal lesions that do not respond to standard therapy. In addition to DFUs classic KS lesions can mimic other conditions such as pyogenic granuloma, melanoma, melanocytic nevi, arteriovenous malformations or severe stasis dermatitis [17]. The acronym “ABCDE” (asymmetry, border, color, diameter, and elevation) has longed served as a diagnostic protocol for melanoma. Additionally, ‘CUBED’ is an alternative acronym that can be used to aid clinicians in the diagnosis of suspicious lesions, particularly on the foot. In the ‘CUBED’ acronym: ‘C’ represents color of lesion; ‘U’ for uncertainty of diagnosis; ‘B’ describes bleeding lesions including chronic granulation tissue; “E” for enlargement or worsening of lesion despite local therapy; and ‘D’ describes delay in healing beyond 2 months [18]. If a pedal lesion displays any two features of the ‘CUBED’ acronym then biopsy is warranted.

In general patients with diabetes are more susceptible to pathogen infection and tumor growth [19, 20]. Several epidemiological studies describe a possible association between HHV-8 infection and T2DM [21]. More specific correlations have been described in recent literature. Infection with HHV-8 is needed for KS development. However, primary infection alone may not be sufficient for tumor development [6]. Once a patient is infected with HHV-8, the virus is typically latent. Ye et al. demonstrated that high blood glucose levels in patients with diabetes can promote HHV-8 lytic gene expression and replication leading to the development of classic KS [22]. Furthermore, Chang et al. showed that high glucose levels not only increase HHV-8 reactivation in latent cells, but also enhances the susceptibly of various host target cells to HHV-8 infection [23]. To date there is limited evidence related to a possible cause and effect nature of T2DM and HHV-8. More scientific investigations in this area can provide new understandings in diabetic complications and aid in risk stratifications.

The patient’s demographic designation is another interesting component of this case. As stated previously, classic KS is most commonly seen in elderly Mediterranean men. In recent years KS in African-American males has been linked to an HIV seropositive status [24]. African-American adults have a higher prevalence of T2DM than Whites [25]. Given the correlations of T2DM and KS, it may be possible that HIV seronegative African-Americans are at a higher risk of KS than previously thought. Classic KS is generally considered not life threatening [26]. Though, increased morbidity has been documented in African-Americans, who tend to have more diffuse tumors, lower cure rates, and decreased survival rates [15]. This could be associated with delayed diagnosis. Due to their violaceous hue, KS lesions can be difficult to detect in patients of darker complexion. Mora and Lee described seronegative HIV KS diagnosed histologically in 19 African-Americans from 1948 to 1983 [27]. Over 50 % of patients had KS lesions, specifically on the foot. Sixteen percent of patients had diabetes and the mortality rate of patients in this series was 21%. In the United States African Americans have the highest death rate and shortest survival rate for most cancers of any racial and ethnic group [28]. As such, clinicians should have a high degree of suspicion for malignancy for atypical skin lesions in this population.

The patient did report that his right fifth digit lesion was precipitated by stubbing the digit. Interestingly, pedal trauma induced KS has been discussed in the literature. Berkowitz et al. described a case in which a 48-year-old HIV positive man developed KS of the right hallux after dropping a piece of wood on the digit [29]. The authors attributed KS in this patient to Koebner phenomenon. Koebner phenomenon, also known as Koebner response, is the development of skin disease at a site of cutaneous injury in patients that are vulnerable to that disease. Though Koebner phenomenon is most commonly associated with psoriasis, it is accepted that KS can occasionally exhibit the response [30]. Even without immunodeficiency, several conditions, including infections, tumors and immune reactions, can locally appear on areas of the body that have been immunologically undermined by trauma [31].

In clinical practice punch biopsy is the most accepted biopsy technique for definitive diagnosis of a classic KS. Punch biopsy provides a full-thickness specimen, which allows for adequate depth for proper diagnosis [32, 33]. In this case report, a shave biopsy was used. The rationale for shave biopsy was the patient’s lesion was small (less than 1.0 cm) and relatively flat. Though in the case presented defining classic KS histologic characteristics were seen utilizing a shave biopsy technique, it must be stressed that superficial shave biopsies can certainly miss important diagnostic features located in deeper tissues. More extensive biopsy techniques include excisional, incisional and core needle. An excisional biopsy is an operative procedure that removes the entire lesion. Incisional biopsies remove only part of the lesion for diagnostic sampling and core needle involves using a fine needle to obtain cells and tissue from the lesion [34].

Treatment for KS depends on the type and number of lesions, the extent of the disease, as well as the overall patient health. [34]. There is no definitive cure for KS [35]. Radiation is now widely used and has been proven effective in treating patients with symptomatic local disease [1, 36]. Due to the local and symptomatic nature of the patient’s disease and his history of diabetes, our institutional Medical Oncology Department and Multidisciplinary Sarcoma Tumor Board recommended local therapy. In regards to radiation therapy there is no universally accepted dose and fractionation [35]. A higher cumulative dose tends to have better results than lower doses [36]. The patient presented was treated with 30 Gy of radiation in 10 fractions and had resolution of his disease. Alternative local disease treatment includes cryotherapy, topical retinoid treatment, curettage and electrodessication, photodynamic therapy and intralesional chemotherapy [34]. Patients with extensive disease or recurrent KS can be managed with a combination of surgery, radiation and chemotherapy [37].


This case is atypical as it shows classic KS in a heterosexual, HIV-seronegative African-American male. Though KS is common in indigenous Africans, classic KS has been described as rare in the American black heterosexual and HIV-seronegative population. Growing literature suggests an association between diabetes and KS, though the specifics of the association are unclear. Given the current perceived rareness of KS in some populations, the clinician should be astute when examining suspicious pedal lesions in patients with diabetes to avoid misdiagnoses and delayed treatment.

Availability of data and materials

Data sharing not applicable to this article as no datasets were generated or analyzed during the current study.



Acquired immune deficiency syndrome


Diabetic foot ulcer


Type 2 diabetes mellitus


Human herpes virus 8


Human immunodeficiency virus


Kaposi sarcoma


Kaposi sarcoma-associated herpes virus


  1. 1.

    Kline A. Kaposi’s sarcoma of the foot: a case report. FAOJ. 2008;3(1).

  2. 2.

    Heyrman B, De Becker A, Schots R. A case report of immunosuppression-related Kaposi's sarcoma after autologous stem cell transplantation. BMC Res Notes. 2016;9:188.

    PubMed  PubMed Central  Article  Google Scholar 

  3. 3.

    Phavixay L, Raynolds D, Simman R. Non AIDS Kaposi's sarcoma leading to lower extremities wounds, case presentations and discussion. J Am Coll Clin Wound Spec. 2012;4(1):13–5.

    PubMed  Article  Google Scholar 

  4. 4.

    Ruocco E, Ruocco V, Tornesello ML, Gambardella A, Wolf R, Buonaguro FM. Kaposi's sarcoma: etiology and pathogenesis, inducing factors, causal associations, and treatments: facts and controversies. Clin Dermatol. 2013;31(4):413–22.

    PubMed  Article  Google Scholar 

  5. 5.

    Iscovich J, Boffetta P, Franceschi S, Azizi E, Sarid R. Classic kaposi sarcoma: epidemiology and risk factors. Cancer. 2000;88(3):500–17.

    CAS  PubMed  Article  Google Scholar 

  6. 6.

    Dourmishev LA, Dourmishev AL, Palmeri D, Schwartz RA, Lukac DM. Molecular genetics of Kaposi’s sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis. Microbiol Mol Biol Rev. 2003;67(2):175–212 table of contents.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  7. 7.

    Pop-Busui R, Boulton AJ, Feldman EL, Bril V, Freeman R, Malik RA, et al. Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes Care. 2017;40(1):136–54.

    CAS  PubMed  Article  Google Scholar 

  8. 8.

    Rynkiewicz R, Sanders LJ. Kaposi's sarcoma. A report of two cases and literature review. J Am Podiatr Med Assoc. 1986;76(3):137–41.

    CAS  PubMed  Article  Google Scholar 

  9. 9.

    Gill K, Shah J. Kaposi sarcoma in patients with diabetes and wounds. Adv Skin Wound Care. 2006;19(4):196–8 201.

    PubMed  Article  Google Scholar 

  10. 10.

    Koo E, Walsh A, Dickson H. Red flags and alarm bells: an atypical lesion masquerading as a diabetic foot ulcer. J Wound Care. 2012;21(11):550 2.

    CAS  PubMed  Article  Google Scholar 

  11. 11.

    Sivaprakasam V, Chima-Okerek C. An interesting case of diabetic foot ulcer in an HIV-positive patient. Int J STD AIDS. 2015;26(4):285–7.

    PubMed  Article  Google Scholar 

  12. 12.

    Edmonds ME, Foster AV. Diabetic foot ulcers. BMJ. 2006;332(7538):407–10.

    PubMed  PubMed Central  Article  Google Scholar 

  13. 13.

    Ndip A, Jude EB. Emerging evidence for neuroischemic diabetic foot ulcers: model of care and how to adapt practice. Int J Low Extrem Wounds. 2009;8(2):82–94.

    PubMed  Article  Google Scholar 

  14. 14.

    Basalely D, Khan KH, Cavazos GJ, D'Antoni AV, Bakotic BW. Pedal presentation of Kaposi's sarcoma in a non-HIV Hispanic female: a case report and literature review. J Foot Ankle Surg. 2012;51(3):365–8.

    PubMed  Article  Google Scholar 

  15. 15.

    Gloster HM, Neal K. Skin cancer in skin of color. J Am Acad Dermatol. 2006;55(5):741–60 quiz 61-4.

    PubMed  Article  Google Scholar 

  16. 16.

    Shiels RA. A history of Kaposi's sarcoma. J R Soc Med. 1986;79(9):532–4.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  17. 17.

    Schwartz RA, Micali G, Nasca MR, Scuderi L. Kaposi sarcoma: a continuing conundrum. J Am Acad Dermatol. 2008;59(2):179–206.

    PubMed  Article  Google Scholar 

  18. 18.

    Bristow IR, de Berker DA, Acland KM, Turner RJ, Bowling J. Clinical guidelines for the recognition of melanoma of the foot and nail unit. J Foot Ankle Res. 2010;3:25.

    PubMed  PubMed Central  Article  Google Scholar 

  19. 19.

    Joshi N, Caputo GM, Weitekamp MR, Karchmer AW. Infections in patients with diabetes mellitus. N Engl J Med. 1999;341(25):1906–12.

    CAS  PubMed  Article  Google Scholar 

  20. 20.

    Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, Habel LA, et al. Diabetes and cancer: a consensus report. Diabetes Care. 2010;33(7):1674–85.

    PubMed  PubMed Central  Article  Google Scholar 

  21. 21.

    Angius F, Madeddu MA, Pompei R. Commentary: high glucose induces reactivation of latent Kaposi's sarcoma-associated herpesvirus. Front Microbiol. 2017;8:1796.

    PubMed  PubMed Central  Article  Google Scholar 

  22. 22.

    Ye F, Zeng Y, Sha J, Jones T, Kuhne K, Wood C, et al. High glucose induces reactivation of latent Kaposi's sarcoma-associated herpesvirus. J Virol. 2016;90(21):9654–63.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  23. 23.

    Chang PJ, Yang YH, Chen PC, Chen LW, Wang SS, Shih YJ, et al. Diabetes and risk of Kaposi's sarcoma: effects of high glucose on reactivation and infection of Kaposi's sarcoma-associated herpesvirus. Oncotarget. 2017;8(46):80595–611.

    PubMed  PubMed Central  Article  Google Scholar 

  24. 24.

    Royse KE, El Chaer F, Amirian ES, Hartman C, Krown SE, Uldrick TS, et al. Disparities in Kaposi sarcoma incidence and survival in the United States: 2000-2013. PLoS One. 2017;12(8):e0182750.

    PubMed  PubMed Central  Article  Google Scholar 

  25. 25.

    Bancks MP, Kershaw K, Carson AP, Gordon-Larsen P, Schreiner PJ, Carnethon MR. Association of Modifiable Risk Factors in young adulthood with racial disparity in incident type 2 diabetes during middle adulthood. JAMA. 2017;318(24):2457–65.

    PubMed  PubMed Central  Article  Google Scholar 

  26. 26.

    Régnier-Rosencher E, Guillot B, Dupin N. Treatments for classic Kaposi sarcoma: a systematic review of the literature. J Am Acad Dermatol. 2013;68(2):313–31.

    PubMed  Article  Google Scholar 

  27. 27.

    Mora RG, Lee B. Cancer of the skin in blacks. IV. A review of nineteen black patients with Kaposi's sarcoma. J Am Acad Dermatol. 1984;11(4 Pt 1):563–7.

    CAS  PubMed  Article  Google Scholar 

  28. 28.

    Cancer Facts and Figures for African Americans 2016–2018: American Cancer Society. 2016 Accessed 17 Sept 2018.

  29. 29.

    Berkowitz KD, Bonner AC, Makimaa B, Flash JP, Sasken H, Blaise JF. Trauma-induced Kaposi's sarcoma of the hallux. An unusual case. J Am Podiatr Med Assoc. 1998;88(10):500–5.

    CAS  PubMed  Article  Google Scholar 

  30. 30.

    Sagi L, Trau H. The Koebner phenomenon. Clin Dermatol. 2011;29(2):231–6.

    PubMed  Article  Google Scholar 

  31. 31.

    Ruocco V, Brasiello M, Szolnoky G, Brunetti G, Ruocco E. Kaposi's sarcoma restricted to an immunocompromised district. Dermatology. 2011;223(3):211–2.

    PubMed  Article  Google Scholar 

  32. 32.

    Pickett H. Shave and punch biopsy for skin lesions. Am Fam Physician. 2011;84(9):995–1002.

    PubMed  Google Scholar 

  33. 33.

    Grayson W, Pantanowitz L. Histological variants of cutaneous Kaposi sarcoma. Diagn Pathol. 2008;3:31.

    PubMed  PubMed Central  Article  Google Scholar 

  34. 34.

    Schmidt BM, Holmes CM. Classic solitary Kaposi sarcoma of the foot in an immunocompetent patient: a case report. Wounds. 2016;28(9):E35–40.

    PubMed  Google Scholar 

  35. 35.

    Al Hammadi NM, Perkins G, Rasul K, Wannenmacher M. Classic kaposi's sarcoma: a case report and literature review. Qatar Med J. 2011;20(2):56–8.

    Google Scholar 

  36. 36.

    Stein ME, Lakier R, Spencer D, Dale J, Kuten A, MacPhail P, et al. Radiation therapy for non-AIDS associated (classic and endemic African) and epidemic Kaposi's sarcoma. Int J Radiat Oncol Biol Phys. 1994;28(3):613–9.

    CAS  PubMed  Article  Google Scholar 

  37. 37.

    Antman K, Chang Y. Kaposi's sarcoma. N Engl J Med. 2000;342(14):1027–38.

    CAS  PubMed  Article  Google Scholar 

Download references


The authors would like to thank May Chan, MD of the University of Michigan Hospital and Health Systems Department of Pathology for her aid in obtaining and interpreting the histopathology slides.



Author information




GT and JW contributed edits of this manuscript. Both authors read and approved the final manuscript.

Corresponding authors

Correspondence to Garneisha M. Torrence or James S. Wrobel.

Ethics declarations

Ethics approval and consent to participate

Ethics approval and consent to participate was not waived as this is a single case report.

Consent for publication

Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Torrence, G.M., Wrobel, J.S. A case of mistaken identity: classic Kaposi sarcoma misdiagnosed as a diabetic foot ulcer in an atypical patient. Clin Diabetes Endocrinol 5, 8 (2019).

Download citation


  • Kaposi sarcoma
  • Malignancy
  • Diabetes mellitus
  • Foot tumor
  • Biopsy